As with the brand-name version, generic Taxol is used to treat various types of cancer, such as breast cancer, lung cancer, and prostate cancer. Several companies currently manufacture the product, including Ivax Pharmaceuticals, Bedford Laboratories, and Dabur Pharma. While generic Taxol is usually sold under the name Paclitaxel Injection, Ivax Pharmaceuticals has named its generic version Onxol.
Taxol® (paclitaxel) is a prescription medication used to treat various types of cancer, including breast cancer, lung cancer, and prostate cancer. It is part of a group of chemotherapy medications called taxanes.
Taxol is made by Bristol-Myers Squibb. However, the patent has since expired, and generic Taxol is now available.
Generic Taxol is made by the following companies:
- Dabur Pharma
- Bedford Laboratories
- Mayne Pharma, Inc.
- Ivax Pharmaceuticals.
Generic Taxol is usually sold under the name Paclitaxel Injection, although Ivax Pharmaceuticals has chosen to give its generic Taxol a new name -- Onxol®.
All generic medications must have certain tests to compare them to brand-name medications. The U.S. Food and Drug Administration (FDA) then looks at these tests to decide if the generic versions are equivalent to the brand-name medications and assigns a rating to each one. An "AP" rating for injectable medications means that the FDA has determined that a generic medication is equivalent to a brand-name medication. All of the generic paclitaxel versions currently available have an "AP" rating, meaning they are considered equivalent to Taxol.